Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Smoking Cessation in Mild-to-Moderate COPD
NCT00285012Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of varenicline in nicotine dependence, sponsored by Pfizer. Started May 2006; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00285012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00285012.